SCD and cancer: Indeed, enzymes within the Fatty Acid (FA) synthesis pathway, such as Acetyl-coA-A Lyase (ACLY), Acetyl-CoA-A Carboxylase (ACC) and Stearoyl-CoA desaturase-1 (SCD-1) have been targets of pharmacological inhibitors in an attempt to decrease their effect on cancer cell proliferation [13,14,15,16].